innovation compounding semaglutide A secret shopper study found that the majority of weight-loss clinics and medical spas in two states offered compounded tirzepatide and after shortages were resolved. Over half of the suppliers combined INNOVATION COMPOUNDING - Updated August

Not a single large, double blind randomized trial showing efficacy and safety in treatment of addiction has been conducted so far

In a statement to The Hill, Novo Nordisk, the maker of Ozempic and Wegovy, said it takes all reports about adverse effects from its medications seriously, but that NAION isn't "an adverse drug reaction for the marketed formulations of semaglutide as per the approved labels." Ozempic is currently FDA-approved to treat Type 2 diabetes and lower certain patients' cardiovascular risk, while Wegovy is FDA-approved for weight loss

Glucagon-like peptide 1 (GLP-1). Molecular Metabolism, 2019

Use the SeekPeptides peptide calculator to determine your exact syringe measurements regardless of which starting dose you choose